Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Carlsmed, Inc. (CARL)
Company Research
Source: Yahoo! Finance
CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. "We delivered another very strong quarter with 61% revenue growth year-over-year, gross margin expansion to 76.5%, and reduction of our lead times to within six business days. These achievements demonstrate our momentum and the speed at which we are scaling while maintaining our culture of patient-centric innovation,” said Mike Cordonnier, Chairman and CEO of Carlsmed. “With recent published data from a patient-matched cohort showing a 74% reduction in revision rates at two years for aprevo ® lumbar patients versus non-aprevo patients, we continue to advance our mission of improved outcomes and reduced cost of healthcare with a highly differentiated approach.” Recent Business Highlights
Show less
Read more
Impact Snapshot
Event Time:
CARL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CARL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CARL alerts
High impacting Carlsmed, Inc. news events
Weekly update
A roundup of the hottest topics
CARL
News
- Carlsmed (CARL) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- Carlsmed, Inc. GAAP EPS of -$0.32 beats by $0.11, revenue of $15.2M beats by $0.34M [Seeking Alpha]Seeking Alpha
- Carlsmed Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire
- Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference [Yahoo! Finance]Yahoo! Finance
CARL
Earnings
- 2/25/26 - Beat
CARL
Sec Filings
- 3/2/26 - Form 144
- 2/25/26 - Form S-8
- 2/25/26 - Form 10-K
- CARL's page on the SEC website